Curative effect analysis of Da Vinci? Robot-assisted surgery for 339 cases with mediastinal tumor: a single center retrospective case-control study
10.3760/cma.j.cn112434-20201101-00491
- VernacularTitle:达芬奇机器人辅助纵隔肿瘤切除术339例近期疗效分析：一项单中心回顾性病例对照研究
- Author:
Yu YANG
1
;
Xuefei ZHANG
;
Teng MAO
;
Zhitao GU
;
Wentao FANG
;
Dingzhong HU
;
Qingquan LUO
Author Information
1. 上海市胸科医院胸外科 200030
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2020;36(11):660-663
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the efficacy of Da Vinci robot-assisted surgery for mediastinal tumor, and summarize the value of Da Vinci system in mediastinal surgery.Methods:The clinical data of 339 cases of robot-assisted mediastinal mass in Shanghai Chest Hospital from April 2015 to September 2020 were retrospectively analyzed, to compare perioperative outcomes of robotic surgery and conventional video-assisted thoracoscopic surgery 2 949 cases.Results:All the operations were successfully completed as planned. No residual lesions, conversion or second operation was observed in the consecutive cohort. The operating time[(81.8±36.8)min vs.(95.6±58.3)min, P=0.015]and post-operation stay[(3.1±1.9)days vs.(3.8±2.3)days, P=0.002] were statistically shorter in robotic group than those inconventional thoracoscopic group. Intraoperative blood loss in two groups was similar[(43.2±22.6)ml vs.(44.0±33.4)ml, P>0.05]. Conclusion:The Da Vinci robot system in mediastinal surgery is safe and feasible with great perspective in the new age of minimally invasive thoracic surgery. Compared with thoracoscopic surgery, it can shorten the operation time and reduce the postoperative hospital stay. It has certain advantages in operator experience and patient recovery.
